COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,722 Articles (22,502 medRxiv, 8,220 bioRxiv)

Most recent first Previous |  Page 2124: Articles 21231-21240  | Next

Estimated Seroprevalence of SARS-CoV-2 Antibodies Among Adults in Orange County, California
Bruckner, T.-A., Parker, D. M., Bartell, S., Vieira, V., Khan, S., Noymer, A., Drum, E., Albala, B., Zahn, M., Boden-Albala, B.
10.1101/2020.10.07.20208660 — Posted: 2020-10-12 Discussion: Onsite
The effect of salt on the dynamics of CoV-2 RBD at ACE2
Peter, E., Schug, A.
10.1101/2020.10.09.333948 — Posted: 2020-10-12 Discussion: Onsite
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2
Zhao, D., Xu, W., Zhang, X., Wang, X., Yuan, E., Xiong, Y., Wu, S., Li, S., Wu, N., Tian, T., Feng, X., Shu, H., Lang, P., Shen, X., Li, H., Li, P., Zeng, J.
10.1101/2020.10.09.332734 — Posted: 2020-10-12
SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.
Boppana, S., Qin, K., Files, J. K., Russell, R. M., Stoltz, R., Bibollet-Ruche, F., Bansal, A., Erdmann, N., Hahn, B. H., Goepfert, P. A.
10.1101/2020.10.07.20208488 — Posted: 2020-10-12
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana
Andronico, A., Tran Kiem, C., Paireau, J., Succo, T., Bosetti, P., Lefrancq, N., Nacher, M., Djossou, F., Sanna, A., Flamand, C., Salje, H., Rousseau, C., Cauchemez, S.
10.1101/2020.10.07.20208314 — Posted: 2020-10-12
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence in the United States
chiu, W., Ndeffo-Mbah, M. L.
10.1101/2020.10.07.20208504 — Posted: 2020-10-12
Forecasting COVID-19 cases in the Philippines using various mathematical models
Torres, M. C., Buhat, C. A. H., Dela Cruz, B. P. C., Felix, E. F. O., Gemida, E. B., Mamplata, J. B.
10.1101/2020.10.07.20208421 — Posted: 2020-10-12
An Innovative Non-Pharmaceutical Intervention to Mitigate SARS-CoV02 Spread: Probability Sampling to Identify and Isolate Asymptomatic Cases
Williams, N. E., Yao, X., Pall, A., Qian, X., Rathod, M., Xu, C., Dobra, A.
10.1101/2020.10.07.20208686 — Posted: 2020-10-12
Safely Reopening K-12 Schools During the COVID-19 Pandemic
Shelley, C. D., Chadwick, P. S., Manore, C., Del Valle, S. Y.
10.1101/2020.10.07.20208710 — Posted: 2020-10-12
Rapid detection of SARS-CoV2 by Ambient Mass Spectrometry Techniques
Ford, L. L., Simon, D., Balog, J., Jiwa, N., Higginson, J., Jones, E., Manoli, E., Mason, S., Wu, V., Stavrakaki, S., McKenzie, J., McGill, D., Koguna, H., Kinross, J., Takats, Z.
10.1101/2020.10.07.20207647 — Posted: 2020-10-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).